glp-1 anesthesia guidelines Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus GLP-1 medications safe to continue

Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis

GLP-1 analogues as adjunctive therapy for type 1 diabetes: systematic review and meta-analysis (24 RCTs, N=3,377)

In cardiovascular conditions, plaques exhibit variability in lipid core size, fibrosis, and immune cell content, while heart failure is marked by patchy myocardial fibrosis and ischemic zones

Nauck, J

Clinical trial averages describe groups of patients

The patient told medical staff at the emergency department that he typically had good blood sugar control using an insulin pump, but he arrived at the hospital with a blood glucose reading over 300 mg/dl